Article
Is there additional effect of MTHFR C677T mutation on lipid abnormalities in renal allograft recipients?
Transplantation proceedings - 1 Jun 2003
Yilmaz H, Agachan B, Isbir T, Akoglu E
Abstract excerpt
BACKGROUND: The MTHFR C677T mutation and elevated atherogenic lipoprotein levels are known as cardiovascular risk factors in patients with renal transplantation treated with cyclosporine (CsA). The aim of the present study was to eveluate the contribution of MTHFR C677T mutation to the risk of dyslipidemia in renal transplant recipients. We also studied the effect of the MTHFR-C677 T genotype on transplant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
